Navigation Links
Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
Date:8/19/2007

FREMONT, Calif., Aug. 17 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH) announced that on August 15, 2007 it received a letter from the Nasdaq Stock Market that indicated the Company is not in compliance with Marketplace Rule 4310(c)(3), which requires it to have (i) a minimum of $2,500,000 in stockholders' equity; (ii) $35,000,000 market value of listed securities; or (iii) $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years.

In accordance with Marketplace Rule 4310(c)(8)(C), the Company has a minimum of 30 calendar days, or until September 14, 2007, to regain compliance. If, at any time prior to September 14, 2007, the market value of the Company's common stock is $35,000,000 or more for at least 10 consecutive business days, Nasdaq may determine that the Company complies with this Rule. If the Company does not achieve this requirement by September 14, 2007, Nasdaq may provide written notification that the Company's securities will be delisted. At that time, the Company may appeal Nasdaq's decision.

About Ciphergen

Ciphergen Biosystems, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Ciphergen, along with its scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Ciphergen is based in Fremont, California. More information about Ciphergen can be found on the Web at http://www.ciphergen.com.


'/>"/>
SOURCE Ciphergen Biosystems, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1

Related biology technology :

1. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
2. Amplified Fragment Length Polymorphism (AFLP) Analysis on Applied Biosystems Capillary Electrophoresis Systems
3. Medical College receives $377K to study brain disease
4. Lucigen receives $750K grant to boost biofuel yields
5. Medical College receives $1.4M cancer grant
6. Wisconsin biotech firm receives $107K NIH grant
7. InvivoSciences receives NIH grant for heart technology
8. Medical College receives $11 million grant to study high blood pressure
9. Madison business receives $115,000 of new state biofuels funding
10. Superior receives funds for technical training
11. UWM receives state funding for plastics research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...tly announced that Dr. Dominique Hebrault will pre...alytical Technology (PAT) in Green Chemistry and G... (PRWEB) November 20, 2009 --...logy (PAT) in Green Chemistry and Green Engineerin...ology (PAT) case studies will be presented on how ...
(Date:11/19/2009)...all/ -- Omeros Corporation (Nasdaq: OMER ) today ...d quarter ended September 30, 2009. For the three ... net loss of $3.9 million, or $1.34 per share, as ...er share, for the same period in 2008. For the nin...orted a net loss of $15.5 million, or $5.29 per sh...
(Date:11/19/2009)...Call/ -- NeoStem, Inc. (NYSE Amex: NBS ), announc...its shareholders, discussing the Company,s acquisi...cals Holdings, Inc. (CHBP), an integrated bio-phar...of China. The merger gives NeoStem a controlling 5..., CHBP,s primary operating subsidiary and a promin...
(Date:11/19/2009)...9 MONITORING FORCE GmbH,announced ...serin in the,indication treatment-relevant levodop...phan drug status designation with the European Med...is a complication of the mainstay,treatment in adv...those,affected, since it may be disabling for the ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...Eden Prairie-,based molecular diagnostics service ...s appointed Paul J. Hoedeman as its CFO, and Eliza...ory. Mr. Hoedeman was recently CFO of Edwin Watts...at Home Depot, CFO and CIO of Allied Signal,Aerosp...He holds a J.D.,from William Mitchell College of L...
...ica, Oct. 11, Iomai Corporation (Nasdaq: IOMI ) t... Gregory Glenn, M.D., presented an,overview of the...,travelers, diarrhea and the implications such a v... Symposia: Challenges of Global Vaccine,Developmen...th, Dr. Glenn presented data from a Phase 2 field ...
...acy staff with the ability to manage ...EW, Calif. and CHAMBERSBURG, Pa., Oct. 11, Omnicel...stem solutions to acute healthcare facilities, and...lth, today announced that Chambersburg,Hospital ha...inutes after,the successful installation of the Om...
Other Biology Technology:Access Genetics Announces New Executive Appointments 2Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 2Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 3Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 4Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0 2Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0 3
(Date:11/20/2009)... contribute their abstracts to the World Congress ...st global meeting devoted to all aspects of osteop...e. The Congress will be held in Florence, Italy fr...an be submitted online at http://www.iofwco-ecceo..., 2010. , IOF and ESCEO are pleased to announce ...
(Date:11/20/2009)... single bacterial gene into yeast, researchers fro...s achieved three improvements in bioethanol produc...ol, less acetate and elimination of the major by-p...shed in the scientific journal Applied and Enviro...ol is made by the yeast Saccharomyces cerevisiae f...
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 1Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 2Nycomed Announces FDA Filing for Daxas 28R 29 in COPD 52082 3United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 1United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 2United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 3Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2
...ecesses of our noses and upper respiratory tracts,...t long before these bacteria break through our imm...r bacterial species to colonize the mucus-lined su...mon nose bacteria involves some interesting tricke...e,re looking at how bacteria use their host, and w...
...ity of Oregon scientists to replicate an extreme r... test and understand the human body,s response to ...ironmental chamber, is a 12-foot-square room capab...ng temperature constant at a set point between 14 ...ty anywhere from 10 to 95 percent. The chamber is ...
... a chief of an immunology laboratory of the Nation...in the past few years for the experts in the under...atzinger has developed the "danger model," suggest...damage detected on the basis of a biological cell,...ders, such as viruses. If Matzinger is correct, th...
Other Biology News:Going To Extremes To Improve Human Health 2Researchers seek to discover what really happens when a virus enters the body 2Researchers seek to discover what really happens when a virus enters the body 3
... needs in both the 384-well format and 96-well for... for a variety applications in the field of Drug D...imization) and Research. , Unmatched wash speed ...hing in both 384-well and 96-well plates. The inst...
...Protein Interaction Reagent A powerful new method...on as an in vitro method for protein interaction d... the exclusive Pierce ProFound Sulfo-SBED Biotin L... relating to protein interactions. • The ...
...nd stackable multi-function incubator. It uses a m...en to accurately control temperature and agitation...e temperature in the incubator. Temperature can be...ler. Built in maintenance-free stepping motor for ...
...nd stackable multi-function incubator. It uses a m...en to accurately control temperature and agitation...e temperature in the incubator. Temperature can be...ler. Built in maintenance-free stepping motor for ...
Biology Products: